Kinase, in vitro: 

An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.

CAMK2B S21-p
PKACA S21-p
PKACA S21-p
PKCB S21-p
 Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

Akt1 S21-p
CAMK2B S21-p
PKACA S21-p
Regulatory protein:
ADCY6 S21-p
Akt1 S21-p
FAK S21-p
GSK3A S21-p , Y279-p
GSK3B S21-p , Y279-p
IRS1 S21-p
SGK1 S21-p
Treatment:
1400W S21-p
acadesine S21-p
action_potential S21-p
AEBSF S21-p
Akt-I-1,2 S21-p
Akt_inhibitor_X S21-p
angiotensin_2 S21-p
anti-TNFalpha S21-p
API-2 S21-p
APV S21-p
BDNF Y279-p
BW373U86 S21-p , Y279-p
cAMP_analog S21-p
cGMP_analog S21-p
CHIR99021 S21-p
CNQX S21-p
colforsin S21-p
culturing_of_cells S21-p , Y279-p
depolarization S21-p , Y279-p
EGF T19-p , S21-p
exercise S21-p
fasting S21-p
fibronectin S21-p
genistein Y279-p
GLP-2 S21-p
glucose T19-p , S21-p
GSK-3_inhibitor_I S21-p , Y279-p
GSK-3_inhibitor_VII S21-p , Y279-p
H-89 S21-p
hypoxia S21-p
IgE S21-p
IGF-1 T19-p , S21-p
indirubin S21-p
insulin S21-p
ischemia/reperfusion S21-p , Y279-p
isoproterenol S21-p
KN-62 S21-p
lithium S21-p , Y279-p
LPA S21-p , Y279-p
LY294002 S21-p , Y279-p
morphine S21-p , Y279-p
myricetin S21-p
PD98059 S21-p , Y279-p
PDGF S20-p , Y279-p
phenylephrine S21-p
phorbol_ester S21-p
PIK90 S21-p
PKI S21-p
PP242 S21-p
PTX Y279-p
rapamycin S21-p
rosiglitazone S21-p
sepsis S21-p
serum S21-p
siRNA S21-p
SL327 Y279-p
STO-609 S21-p
TGF-alpha T19-p , S21-p
U0126 S21-p
U73122 Y279-p
vanadate Y279-p
wortmannin S21-p